FDA questions Takeda & more: 5 GI industry key notes

Here are five updates from gastroenterology companies and practices from the past week:

The FDA sent Takeda a questioning letter in response to the company's biologics license application concerning the subcutaneous formulation of Entyvio, a maintenance therapy for ulcerative colitis.

Baptist Medical Center in Jacksonville, Fla., built what it believes to be the region's first gastroesophageal reflux center.

South Denver Gastroenterology opened a clinic and endoscopy center in Castle Rock, Colo.

Conmed is leaving the NASDAQ and transferring its listing to the New York Stock Exchange.

Minneapolis-based Colon & Rectal Surgery Associates will join Infinite Health Collaborative in the spring.

More articles on surgery centers: 
Holly Springs Surgery Center renews accreditation
The Joint Commission releases new requirements for total knee & hip certification
California medical board OKs outpatient surgery accreditation program

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers